These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17969072)

  • 1. The challenging patient: HCV and alcoholic liver disease.
    Lucey MR; Lake JR
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S87-8. PubMed ID: 17969072
    [No Abstract]   [Full Text] [Related]  

  • 2. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
    Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
    Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity.
    Mendler M; Kwok H; Franco E; Baron P; Weissman J; Ojogho O
    Liver Transpl; 2008 Sep; 14(9):1313-22. PubMed ID: 18756485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment for alcoholic liver disease with HCV].
    Tsutsumi M; Takada A
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):866-70. PubMed ID: 7563892
    [No Abstract]   [Full Text] [Related]  

  • 5. Revisiting posttransplant survival for hepatitis C virus recipients.
    Kemmer N; Kaiser TE; Zacharias V; Secic M; Neff GW
    Transplantation; 2007 Oct; 84(7):932-3. PubMed ID: 17984849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
    Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
    Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating chronic hepatitis C virus after liver transplantation: balancing the risks against the chance for success.
    Shiffman ML
    Liver Transpl; 2007 Aug; 13(8):1088-91. PubMed ID: 17663409
    [No Abstract]   [Full Text] [Related]  

  • 8. [Histopathological characteristics of alcoholic liver injury in cases with serum HCV markers].
    Uchikoshi T; Maeyama S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):858-65. PubMed ID: 7563891
    [No Abstract]   [Full Text] [Related]  

  • 9. Older donors: mounting risks for the hepatitis C-infected liver transplant recipient?
    Valadao RM; Terrault NA
    Liver Transpl; 2009 Jul; 15(7):677-81. PubMed ID: 19562695
    [No Abstract]   [Full Text] [Related]  

  • 10. Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus.
    Fiel MI; Agarwal K; Stanca C; Elhajj N; Kontorinis N; Thung SN; Schiano TD
    Liver Transpl; 2008 Jun; 14(6):861-71. PubMed ID: 18508382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease.
    Koff RS; Dienstag JL
    Semin Liver Dis; 1995 Feb; 15(1):101-9. PubMed ID: 7597440
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictors of graft and patient survival in subjects undergoing transplantation for hepatitis C virus infection.
    Audimoolam VK; Foxton MR; Agarwal K; O'Grady JG; Heneghan MA
    Liver Transpl; 2010 Apr; 16(4):536-7. PubMed ID: 20373465
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis of alcoholic liver disease with HCV].
    Tsutsumi M; Takase S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):847-51. PubMed ID: 7563887
    [No Abstract]   [Full Text] [Related]  

  • 14. Human immunodeficiency virus and liver transplantation: our point of view.
    Di Benedetto F; Di Sandro S; De Ruvo N; Berretta M; Montalti R; Guerrini GP; Ballarin R; De Blasiis MG; Spaggiari M; Smerieri N; Iemmolo RM; Guaraldi G; Gerunda GE
    Transplant Proc; 2008; 40(6):1965-71. PubMed ID: 18675102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a link between hepatitis C virus and new onset of diabetes mellitus after liver transplantation?
    Thuluvath PJ
    Liver Transpl; 2007 Jan; 13(1):5-7. PubMed ID: 17192890
    [No Abstract]   [Full Text] [Related]  

  • 16. Patient with hepatitis B and alcoholic liver disease before and after liver transplantation.
    Ward SC; Chang CY; Peng L; Liu LU
    Semin Liver Dis; 2009 May; 29(2):233-7. PubMed ID: 19387922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral risk factors for hepatitis C virus in alcoholics with chronic liver diseases.
    Astagneau P; Piette AM; Vignon D; Gepner P; Chapman A
    Eur J Med; 1993 Mar; 2(3):187. PubMed ID: 8261068
    [No Abstract]   [Full Text] [Related]  

  • 18. A patient with alcoholic liver failure referred for liver transplantation.
    Mathurin P; Lucey MR
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S83-6. PubMed ID: 17969071
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical hepatology: alcoholic liver disease, not viral hepatitis, predominates in South Wales.
    Kingham JG
    Hepatology; 1997 May; 25(5):1297. PubMed ID: 9141459
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.